Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Clinical utility of DaTscan in patients with suspected Parkinsonian syndrome: a systematic review and meta-analysis

Autor: Danny Bega, Phillip H. Kuo, Anastasia Chalkidou, Mariusz T. Grzeda, Thomas Macmillan, Christine Brand, Zulfiqar H. Sheikh, Angelo Antonini

Publikováno v: npj Parkinson's Disease, Vol 7, Iss 1, Pp 1-8 (2021)

Abstract Images of DaTscan (ioflupane [123I] SPECT) have been used as an adjunct to clinical diagnosis to facilitate the differential diagnosis of neurodegenerative (ND) Parkinsonian Syndrome (PS) vs. non-dopamine deficiency aetiologies of Parkinsoni

Externí odkaz: https://doaj.org/article/30296b6677c843f7abd230e20597664e

A systematic review of the potential effects of medications and drugs of abuse on dopamine transporter imaging using [123I]I-FP-CIT SPECT in routine practice

Autor: Youssef Chahid, Zulfiqar H. Sheikh, Max Mitropoulos, Jan Booij

Publikováno v: Chahid, Y, Sheikh, Z H, Mitropoulos, M & Booij, J 2023, ' A systematic review of the potential effects of medications and drugs of abuse on dopamine transporter imaging using [123I]I-FP-CIT SPECT in routine practice ', European Journal of Nuclear Medicine and Molecular Imaging, vol. 50, no. 7, pp. 1974-1987 . https://doi.org/10.1007/s00259-023-06171-x

Purpose In routine practice, dopamine transporter (DAT) imaging is frequently used as a diagnostic tool to support the diagnosis of Parkinson’s disease or dementia with Lewy bodies. In 2008, we published a review on which medications and drugs of a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90245f3b11176ba6e6d62ac197de7f67
http://www.scopus.com/inward/record.url?scp=85148946192&partnerID=8YFLogxK

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.